BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10443297)

  • 1. Immunohistochemical study of tenascin in mesangial proliferative (IgA-negative) glomerulonephritis.
    Wagrowska-Danilewicz M; Danilewicz M
    Acta Histochem; 1999 Jul; 101(3):351-9. PubMed ID: 10443297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A correlation between immunoexpression of CD44, alpha-SMA and CD68+ cells in IgA-nephropathy and in mesangial proliferative IgA-negative glomerulonephritis.
    Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 2002; 53(3):155-62. PubMed ID: 12476618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CC chemokines and chemokine receptors in IgA nephropathy (IgAN) and in non-IgA mesangial proliferative glomerulonephritis (MesProGN). the immunohistochemical comparative study.
    Wagrowska-Danilewicz M; Danilewicz M; Stasikowska O
    Pol J Pathol; 2005; 56(3):121-6. PubMed ID: 16334979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intercellular adhesion molecule-1 (ICAM-1), leucocyte function-associated antigen-1 (LFA-1) and leucocyte infiltration in proliferative human glomerulonephritis.
    Wagrowska-Danilewicz M; Danilewicz M
    Acta Histochem; 1998 Apr; 100(2):201-15. PubMed ID: 9587631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenascin is synthesized and secreted by rat mesangial cells in culture and is present in extracellular matrix in human glomerular diseases.
    Truong LD; Majesky MW; Pindur J
    J Am Soc Nephrol; 1994 Apr; 4(10):1771-7. PubMed ID: 7520763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of a brain/embryo-type myosin heavy chain isoform (MIIB2) in mesangial proliferative glomerulonephritis.
    Kishino M; Kimura A; Yamaguchi K; Ohtani H; Yamada Y; Takahashi T; Mune M; Mimura K; Maeda T; Matsumura S; Tsuji T; Yukawa S
    Kidney Int; 1996 May; 49(5):1350-9. PubMed ID: 8731100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
    Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
    Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The morphological heterogeneity of mesangioproliferative glomerulonephritis].
    Gasanov AB; Varshavskiĭ VA; Serov VV
    Arkh Patol; 1990; 52(9):46-51. PubMed ID: 2270980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological changes and tumour necrosis factor-alpha, transforming growth factor-beta and tenascin expression in patients with primary type I membranoproliferative glomerulonephritis in remission.
    Arikan H; Koc M; Cakalagaoglu F; Tuglular S; Ozener C; Akoglu E
    Nephrology (Carlton); 2009 Apr; 14(2):219-26. PubMed ID: 19298642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative immunohistochemical study of the expression of mesangial alpha-smooth muscle actin and the proliferation marker Ki-67 in glomerulonephritis in man.
    Groma V; Marcussen N; Olsen S
    Virchows Arch; 1997 Nov; 431(5):345-50. PubMed ID: 9463576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long pentraxin PTX3 is synthesized in IgA glomerulonephritis and activates mesangial cells.
    Bussolati B; Peri G; Salvidio G; Verzola D; Mantovani A; Camussi G
    J Immunol; 2003 Feb; 170(3):1466-72. PubMed ID: 12538709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of tenascin in mesangial injury in experimental glomerulonephritis.
    Jyo Y; Sasaki T; Nomura S; Tamai H; Kawai S; Osawa G; Nakao N; Kusakabe M
    Exp Nephrol; 1997; 5(5):423-8. PubMed ID: 9386979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary serum cholinesterase deficiency associated with severe lipid deposition in the kidney.
    Honda K; Yumura W; Arai J; Sanaka T; Nihei H; Sugino N
    Intern Med; 1993 Feb; 32(2):145-51. PubMed ID: 8507926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of alphavbeta3, alphavbeta5 integrins and the integrin associated protein--IAP (CD47) in human glomerular diseases.
    Hafdi Z; Lesavre P; Nejjari M; Halbwachs-Mecarelli L; Droz D; Noël LH
    Cell Adhes Commun; 2000; 7(6):441-51. PubMed ID: 11051455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
    Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
    Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sialoadhesin (CD169) expressing a macrophage subset in human proliferative glomerulonephritis.
    Ikezumi Y; Suzuki T; Hayafuji S; Okubo S; Nikolic-Paterson DJ; Kawachi H; Shimizu F; Uchiyama M
    Nephrol Dial Transplant; 2005 Dec; 20(12):2704-13. PubMed ID: 16169862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenascin is an important component of the glomerular extracellular matrix in normal and pathologic conditions.
    Truong LD; Pindur J; Barrios R; D'Agati V; Lechago J; Suki W; Majesky M
    Kidney Int; 1994 Jan; 45(1):201-10. PubMed ID: 7510349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative study of mesangial deposits and glomerular monocytes/macrophages in IgA-nephropathy and proliferative mesangial (non-IgA) glomerulonephritis.
    Danilewicz M; Wagrowska-Danilewicz M
    J Nephrol; 1998; 11(5):255-60. PubMed ID: 9831239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease of mesangial matrix after immunosuppressive therapy in children with reversible membranoproliferative glomerulonephritis type I.
    Inaba S; Tanizawa T; Takahashi T; Ishihara S; Arai M; Sakai Y; Kurose KK; Matsukura H; Okada T
    Clin Nephrol; 1996 Apr; 45(4):217-25. PubMed ID: 8861795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3 modulates rat mesangial cell proliferation and matrix synthesis during experimental glomerulonephritis induced by anti-Thy1.1 antibodies.
    Sasaki S; Bao Q; Hughes RC
    J Pathol; 1999 Mar; 187(4):481-9. PubMed ID: 10398110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.